FDA loosens data rules for medical devices by allowing real-world evidence without patient identifiers in marketing submissions.
Medical Device Network on MSN
FDA removes patient-identifiable RWE requirement for device submissions
The FDA’s change opens the door for RWE gleaned from de-identified data sources to be used for device submissions to the ...
FDA is removing barriers to real-world evidence in device applications, allowing the use of de-identified patient data from ...
The FDA announced that it removed a limitation on the use of real-world evidence (RWE) in drug and device application reviews ...
Neuralink, Elon Musk’s frothy brain-computer interface company, poached David McMullen, director of FDA’s office of ...
The U.S. FDA announced Dec. 15 that it will take a more relaxed approach regarding the use of real-world evidence (RWE) in ...
Medtech industry groups said the FDA should use existing regulatory and quality tools to monitor performance, while medical ...
The FDA’s oversight of medical device recalls continues to be plagued by staffing challenges—forcing some activities to be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results